Compounds > carmustine

carmustine and 3,4-dihydro-5-methyl-1(2h)-isoquinolinone

carmustine has been researched along with 3,4-dihydro-5-methyl-1(2h)-isoquinolinone in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Scavone, SV; Sebolt-Leopold, JS1
Chatterjee, S; Gerson, SL; Liu, L; Taverna, P; Whitacre, CM1

Other Studies

2 other study(ies) available for carmustine and 3,4-dihydro-5-methyl-1(2h)-isoquinolinone

ArticleYear
Enhancement of alkylating agent activity in vitro by PD 128763, a potent poly(ADP-ribose) synthetase inhibitor.
    International journal of radiation oncology, biology, physics, 1992, Volume: 22, Issue:3

    Topics: Alkylating Agents; Animals; Carmustine; Drug Synergism; In Vitro Techniques; Isoquinolines; Leukemia L1210; Misonidazole; Poly(ADP-ribose) Polymerase Inhibitors; Streptozocin; Tumor Cells, Cultured

1992
Pharmacologic disruption of base excision repair sensitizes mismatch repair-deficient and -proficient colon cancer cells to methylating agents.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:10

    Topics: Antineoplastic Agents, Alkylating; Carmustine; Cell Cycle; Colonic Neoplasms; Dacarbazine; DNA Repair; Drug Synergism; Humans; Hydroxylamines; Isoquinolines; Poly(ADP-ribose) Polymerase Inhibitors; Temozolomide

1999